Phone: +44 (0)1462 439877 Email: email@example.com
To ensure a smooth transition from the pre-authorisation to the post-authorisation phase of the life-cycle of a ...
31 Jul, 2019
A Guide to the US FDA Safety Requirements for Pharmacovigilance
QPPV and PSMF requirements update in case of no-deal Brexit
19 Mar, 2019
MHRA e-Submission Update in preparation for Brexit
06 Mar, 2019